BackCalliditas Therapeutics AB Overview
Calliditas Therapeutics AB - ADR

Calliditas Therapeutics AB Target Price

Explore Calliditas Therapeutics AB's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$40

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-05-28JefferiesMaury Raycroft$392.5% downsideOpen
2024-05-28Stifel NicolausAnnabel Samimy$400% upsideOpen
2024-05-23JefferiesMaury Raycroft$5845% upsideOpen

Calliditas Therapeutics AB (CALT) FAQ

Stockcircle tracks target price for Calliditas Therapeutics AB (CALT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Calliditas Therapeutics AB's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CALT overview so you can move from this figure to the surrounding analysis quickly.